Literature DB >> 17412867

Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion.

Haihua Zhang1, Liyan Xu, Dawei Xiao, Jianjun Xie, Hongmei Zeng, Zhaoyang Wang, Xiaoling Zhang, Yongdong Niu, Zhongying Shen, Jinghui Shen, Xuan Wu, Enmin Li.   

Abstract

BACKGROUND: Neutrophil gelatinase-associated lipocalin (NGAL) is a member of the lipocalin family. Recently, an elevated NGAL expression was reported in several types of cancers. However, the characteristics of NGAL expression in oesophageal squamous cell carcinoma (ESCC) are still unknown. AIM: To demonstrate the role of NGAL in ESCC.
METHODS: NGAL expression in 81 paraffin sections, including ESCC, normal mucosa, simple hyperplasia and dysplasia, and in 73 fresh specimens of ESCC was analysed by immunohistochemistry, western blot and gelatin zymography.
RESULTS: On immunohistochemical study, ESCC showed a diverse staining pattern for NGAL. However, only a weak positive signal was present within a restricted cytoplasmic area in the normal oesophageal epithelium. In dysplasia, altered NGAL expression could also be observed. On western blot study, NGAL expression level was found to be significantly higher in ESCC than in normal mucosa (p=0.030), and to be positively correlated with cell differentiation. However, no significant association was observed between NGAL expression and cell proliferation. In addition, the enzymic activity of the NGAL/matrix metalloproteinase 9 complex was much higher in ESCC than in normal mucosa, and was significantly correlated with the depth of tumour invasion in zymography analysis (p=0.006).
CONCLUSIONS: The findings suggest that NGAL is involved in the differentiation pathway and invasive progression of ESCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412867      PMCID: PMC1994524          DOI: 10.1136/jcp.2006.039297

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

Review 1.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

Review 2.  Esophageal cancer: an overview.

Authors:  J A Brooks-Brunn
Journal:  Medsurg Nurs       Date:  2000-10

3.  Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin.

Authors:  Lotus Mallbris; Kevin P O'Brien; Anna Hulthén; Bengt Sandstedt; Jack B Cowland; Niels Borregaard; Mona Ståhle-Bäckdahl
Journal:  Exp Dermatol       Date:  2002-12       Impact factor: 3.960

4.  [Functions of neutrophil gelatinase-associated lipocalin in the esophageal carcinoma cell line SHEEC].

Authors:  En-Min Li; Li-Yan Xu; Wei-Jia Cai; Hua-Qi Xiong; Zhong-Ying Shen; Yi Zeng
Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)       Date:  2003-03

5.  Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7.

Authors:  Z Shen; S Cen; J Shen; W Cai; J Xu; Z Teng; Z Hu; Y Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2000-10       Impact factor: 4.553

6.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.

Authors:  David H Goetz; Margaret A Holmes; Niels Borregaard; Martin E Bluhm; Kenneth N Raymond; Roland K Strong
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

7.  Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells.

Authors:  Ho-Jeong Lee; Eun-Kyoung Lee; Kong-Ju Lee; Soon-Won Hong; Yeup Yoon; Jang-Seong Kim
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

8.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.

Authors:  L Kjeldsen; A H Johnsen; H Sengeløv; N Borregaard
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

9.  Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha.

Authors:  Jack B Cowland; Ole E Sørensen; Maxwell Sehested; Niels Borregaard
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 10.  Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches.

Authors:  Mary Koshy; Natia Esiashvilli; Jerome C Landry; Charles R Thomas; Richard H Matthews
Journal:  Oncologist       Date:  2004
View more
  51 in total

1.  Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.

Authors:  Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Makoto Kuro-o; Orson W Moe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

2.  Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival.

Authors:  Herbert Thomas Maier; Felix Aigner; Birgit Trenkwalder; Matthias Zitt; Natalie Vallant; Alexander Perathoner; Christian Margreiter; Patrizia Moser; Johann Pratschke; Albert Amberger
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

3.  NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis.

Authors:  Ming-Fa Liu; Tao Jin; Jin-Hui Shen; Zhong-Ying Shen; Zhi-Chao Zheng; Zeng-Liang Zhang; Li-Yan Xu; En-Min Li; Hai-Xiong Xu
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

4.  A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cells.

Authors:  Wang-Kai Fang; Li-Yan Xu; Xiao-Feng Lu; Lian-Di Liao; Wei-Jia Cai; Zhong-Ying Shen; En-Min Li
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

5.  Neutrophil gelatinase-associated lipocalin immunoexpression in colorectal carcinoma: A stage-specific prognostic factor?

Authors:  Valeria Barresi; Roberta Lucianò; Enrica Vitarelli; Agata Labate; Giovanni Tuccari; Gaetano Barresi
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

6.  NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models.

Authors:  Yan Sun; Kenji Yokoi; Hui Li; Jun Gao; Limei Hu; Ben Liu; Kexin Chen; Stanley R Hamilton; Dominic Fan; Baocun Sun; Wei Zhang
Journal:  Clin Cancer Res       Date:  2011-05-27       Impact factor: 12.531

7.  Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.

Authors:  Zhimin Tong; Subhankar Chakraborty; Bokyung Sung; Pooja Koolwal; Sukhwinder Kaur; Bharat B Aggarwal; Sendurai A Mani; Robert S Bresalier; Surinder K Batra; Sushovan Guha
Journal:  Cancer       Date:  2010-12-29       Impact factor: 6.860

8.  Lipocalin 2 is required for BCR-ABL-induced tumorigenesis.

Authors:  X Leng; H Lin; T Ding; Y Wang; Y Wu; S Klumpp; T Sun; Y Zhou; P Monaco; J Belmont; A Aderem; S Akira; R Strong; R Arlinghaus
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

9.  Neutrophil gelatinase-associated lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2.

Authors:  Parisa Bahmani; Raheleh Halabian; Mehdi Rouhbakhsh; Amaneh Mohammadi Roushandeh; Nasser Masroori; Majid Ebrahimi; Ali Samadikuchaksaraei; Mohammad Ali Shokrgozar; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2009-11-11       Impact factor: 3.667

10.  Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.

Authors:  Xeni Provatopoulou; Antonia Gounaris; Eleni Kalogera; Flora Zagouri; Ioannis Flessas; Evgenios Goussetis; Afroditi Nonni; Ioannis Papassotiriou; George Zografos
Journal:  BMC Cancer       Date:  2009-11-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.